Observatoire des droits humains (anglais seulement)

Cholesterol jab: why gene silencing drugs may work better than current treatments

(Version anglaise seulement)

par Aristides Tagalakis, Reader in Gene Delivery and Nanomedicine, Edge Hill University

The NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.

The drug – inclisiran – will be administered twice a year as an injection. It will mainly be prescribed to patients who suffer with a genetic condition that leads to high cholesterol, those who have already suffered a heart attack or stroke, or those who haven’t…

Lire l'article complet